Scholars@Duke

Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for the prevention of deep venous thrombosis?

Publication ,  Journal Article
Zhou, A; Winkler, A; Emamifar, A; Gartland, B; Duncan, A; Antun, A; Arellano, M; Tindol, GA; Levy, JH; Bornstein, WA; Horowitz, IR; Khoury, HJ
Published in: Chest
2012

Duke Scholars

Jerrold Henry Levy
Author Jerrold Henry Levy Anesthesiology, Cardiothoracic

Published In

Chest

ISSN

1931-3543

Publication Date

2012

Volume

142

Issue

5

Start / End Page

1175 / 1178

Publisher

Elsevier

Related Subject Headings

  • Respiratory System
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhou, A., Winkler, A., Emamifar, A., Gartland, B., Duncan, A., Antun, A., … Khoury, H. J. (2012). Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for the prevention of deep venous thrombosis? Chest, 142(5), 1175–1178.
Zhou, A., A. Winkler, A. Emamifar, B. Gartland, A. Duncan, A. Antun, M. Arellano, et al. “Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for the prevention of deep venous thrombosis?” Chest 142, no. 5 (2012): 1175–78.
Zhou A, Winkler A, Emamifar A, Gartland B, Duncan A, Antun A, et al. Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for the prevention of deep venous thrombosis? Chest. 2012;142(5):1175–8.
Zhou A, Winkler A, Emamifar A, Gartland B, Duncan A, Antun A, Arellano M, Tindol GA, Levy JH, Bornstein WA, Horowitz IR, Khoury HJ. Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for the prevention of deep venous thrombosis? Chest. Elsevier; 2012;142(5):1175–1178.

Published In

Chest

ISSN

1931-3543

Publication Date

2012

Volume

142

Issue

5

Start / End Page

1175 / 1178

Publisher

Elsevier

Related Subject Headings

  • Respiratory System
  • 1103 Clinical Sciences